News

Researchers have identified urolithins are the molecules responsible for pomegranate extract’s apparent neuroprotective effectives against Alzheimer’s disease. The study, entitled “Pomegranate’s Neuroprotective Effects against Alzheimer’s Disease Are Mediated by Urolithins, Its Ellagitannin-Gut Microbial Derived Metabolites,” was published in ACS Chemical Neuroscience. Several animal studies have demonstrated that pomegranate…

MitoQ, the world’s first antioxidant formula demonstrating ability to penetrate mitochondria in order to deliver antioxidants in meaningful levels, has been selected for the USA’s National Institute of Aging’s (NIA) Interventions Testing Program (ITP) — an internationally recognized anti-aging testing program funded by the US Government — reports…

High levels of stress can increase the likelihood of elderly people developing mild cognitive impairment — usually a precursor to Alzheimer’s disease. These results are reported in a study titled “Influence of Perceived Stress on Incident Amnestic Mild Cognitive Impairment: Results From the Einstein Aging Study,” published in the…

Scientists with the University Health Network (UHN) in Toronto, Canada, have discovered a method of diagnosing Alzheimer’s disease with more than 80 percent accuracy. The innovative technique evaluates the interplay between four linguistic factors, and the researchers are developing automated technology to detect these impairments. The study, led by…

Researchers discovered a potential cause for the disrupted sleep patterns observed in Alzheimer’s disease patients. The study, “Melanopsin retinal ganglion cell loss in Alzheimer’s disease,” associates the degradation of a subset of eye cells involved in circadian rhythm regulation with the sleep dysfunction observed in AD, and was published in…

Men undergoing androgen deprivation therapy (ADT) for prostate cancer  could be almost twice as likely to be diagnosed with Alzheimer’s disease (AD) than those not treated with ADT. The findings, in a study published in the Journal of Clinical Oncology, also show that the risks of developing Alzheimer’s might continue…

A recent study suggests that amyloid beta plaques may alter normal blood flow to brain tissue and contribute to development of Alzheimer’s disease. The paper, published in the journal Brain, is entitled “Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer’s disease.”…

Yale School of Public Health researchers have demonstrated that stress caused by negative attitudes and beliefs toward aging can lead to pathological brain damage associated with Alzheimer’s disease. The research paper, the first to correlate a cultural and psychosocial risk factor to Alzheimer’s disease onset, was published online in the…

Alzheimer’s disease and cognitive deficits could be linked to reduced neuronal levels of BRCA1, a protein typically targeted in cancer research. These were the results of a study entitled “DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice,” published in Nature Communications.

Researchers have discovered a network of nine genes that play a key role in Alzheimer’s disease onset. The study entitled “APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease” was published in the journal Molecular Psychiatry. Alzheimer’s disease age of onset varies greatly between individuals, a phenotype…